Mercer Global Advisors Inc Neurocrine Biosciences Inc Transaction History

Mercer Global Advisors Inc

$48.3 Billion
Q2 2025

A detailed history of Mercer Global Advisors Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 13,961 shares of NBIX stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,961

Previous 11,982 16.52%

Holding current value

$1.98 Million

Previous $1.33 Million 32.38%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$87.54 - $128.18 $173,241 - $253,668	1,979 Added 16.52%	13,961 $1.75 Million
Q1 2025 May 15, 2025	SELL	$107.22 - $153.29 $13,938 - $19,927	-130 Reduced 1.07%	11,982 $1.33 Million
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $462,441 - $577,699	4,143 Added 51.99%	12,112 $1.65 Million
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $17,645 - $23,585	-154 Reduced 1.9%	7,969 $917,000
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $56,269 - $61,571	430 Added 5.59%	8,123 $1.12 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $313,090 - $345,119	2,401 Added 45.37%	7,693 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $129,299 - $161,834	1,219 Added 29.93%	5,292 $697,000
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $65,625 - $81,735	698 Added 20.68%	4,073 $458,000
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $10,833 - $12,689	121 Added 3.72%	3,375 $318,000
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $15,810 - $20,667	168 Added 5.44%	3,254 $329,000
Q4 2022 Feb 08, 2023	BUY	$106.72 - $127.06 $27,640 - $32,908	259 Added 9.16%	3,086 $369,000
Q3 2022 Nov 15, 2022	SELL	$92.03 - $107.81 $49,696 - $58,217	-540 Reduced 16.04%	2,827 $300,000
Q2 2022 Aug 10, 2022	BUY	$75.79 - $100.07 $32,589 - $43,030	430 Added 14.64%	3,367 $328,000
Q1 2022 May 10, 2022	BUY	$72.45 - $94.81 $212,785 - $278,456	2,937 New	2,937 $275,000
Q2 2021 Aug 10, 2021	SELL	$89.43 - $102.27 $264,712 - $302,719	-2,960 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$87.57 - $119.4 $49,739 - $67,819	568 Added 23.75%	2,960 $288,000
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $207,888 - $259,125	2,392 New	2,392 $229,000
Q3 2020 Dec 10, 2020	SELL	$96.16 - $135.15 $177,126 - $248,946	-1,842 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $156,735 - $240,123	1,842 New	1,842 $225,000

Others Institutions Holding NBIX

# of Institutions

687

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Neurocrine Biosciences Inc Transaction History